Zacks Investment Research on MSN47mOpinion
Jazz Offers to Buy Chimerix for $935M to Boost Oncology PortfolioJazz Pharmaceuticals JAZZ announced that it has entered into a definitive agreement to acquire all the outstanding shares of ...
In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback